Elsevier,
Australian and New Zealand Journal of Public Health, Volume 47, June 2023
This article highlights that although Indigenous research governance is recognised as an essential part of ethical Aboriginal and Torres Strait Islander research, activities and contributions made by Indigenous reference group (IRG) members are underreported.
Elsevier,
The Lancet Global Health, Volume 11, June 2023
This Article supports SDG 3 by presenting a conceptual framework and a method to estimate cost-effectiveness thresholds for 174 countries, using public and widely available data on country-specific health expenditures and health outcomes; these findings can inform policy makers on the thresholds to consider when deciding on the allocation of health resources.
Elsevier,
The Lancet Gastroenterology and Hepatology, Volume 8, June 2023
This Article supports SDG 3 by assessing the incidence of HIV and HCV infection among people who inject drugs, a population at higher risk of these infections. In this systematic review, HCV estimates came from studies in 24 countries. Pooled HCV incidence was 12.1 per 100 person-years; data for both infections were scarce, suggesting increased efforts are needed to keep track of these infections in this population.
Lancet Regional Health - Americas, Volume 22, June 2023
This Article supports SDG 3 by using modelling to estimate the impact of immigration on hepatitis B prevalence in the USA, in order to more accurately assess the hepatitis B burden, which might not be accurately measured by national serosurveys. The study found a significantly higher burden of hepatitis B (1.8 million cases), significantly higher than that found in national serosurveys.
Elsevier,
Lancet Regional Health - Americas, Volume 22, June 2023
This Article supports SDG 3 by showing that an HCV testing (point-of-care) and treatment programme implemented in users of a supervised drug cosumption service in Canada was beneficial, with a large degree of positive testing, testing acceptance, and treatment engagement. The study suggests that on-site point of care testing and treatment for HCV in supervised consumption services is effective in reaching this population
Elsevier,
The Lancet Rheumatology, Volume 5, June 2023
This Article supports SDG 3 by estimating the burden of low back pain, which continues to be the leading cause of disability worldwide. The study predicts that low back pain prevalence will continue to increase, from 619 million people in 2020 to 843 million in 2050. Two-fifths of the burden are due to modifiable risk factors, and a quarter of years lived with disability are attributable to occupational ergonomic factors.
Elsevier,
The Lancet Global Health, Volume 11, June 2023
This Comment supports SDGs 4 and 10 by reviewing the global pledges and resolutions that have been made regarding disabled children (dating back to 1946), and highlighting how the September 2023 global summit on SDGs provides an opportunity to reaffirm global commitments on early childhood development.
Elsevier,
American Journal of Clinical Nutrition, Volume 117, June 2023
This paper concludes that findings suggest that 1) long-term omega-3 fatty acid supplementation may reduce risk of Alzheimer’s disease (AD); 2) dietary omega-3 fatty acid intake, especially DHA, may lower risk of dementia or cognitive decline; and 3) peripheral biomarkers of omega-3 fatty acids may serve as predictors of cognitive decline. However, further investigation is needed to understand the gene–environment interactions involved in the intake of omega-3 fatty acids.
